ERC, Epitopoietic Research Corporation,

Founded

2012

Status

active

Website

erc-immunotherapy.com

Sector

cell-based-immunotherapy, cancer-treatment, biotechnology-research, therapeutic-development

TLDR

ERC develops patented cell-based immunotherapy treatments that stimulate the patient's immune system against tumors using autologous and allogeneic tumor cell lysates.

Overview

ERC uses a unique patented approach to treat tumours by directly stimulating the patient's immune system. The company's technology employs whole cells and lysates derived from autologous and allogeneic tumor cells as the basis for its immunotherapy treatments.

Filed under

companies cell-based-immunotherapy cancer-treatment biotechnology-research therapeutic-development